Therapeutic Asset Ratings
2,003 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Humax-Cd20
Burkitt Lymphoma
M.D. Anderson Cancer Center
P2
B
(62)
Humax-Cd20
Recurrent Burkitt Lymphoma
M.D. Anderson Cancer Center
P2
B
(62)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Ovarian Carcinoma
M.D. Anderson Cancer Center
P2
B
(62)
Ipilimumab
Hematopoietic And Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center
P2
B
(62)
Ketorolac Tromethamine
MDS
M.D. Anderson Cancer Center
P2
B
(62)
Nivolumab
B-Cell Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center
P2
B
(62)
TACROLIMUS
Lymphoproliferative Syndrome
M.D. Anderson Cancer Center
P2
B
(62)
Venetoclax
Lymphoma
M.D. Anderson Cancer Center
P2
B
(62)
Apg-2575
Lisaftoclax
M.D. Anderson Cancer Center
P2/3
B
(62)
Cediranib
Blastic Phase Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center
P1/2
B
(62)
Cytosin-Arabinosid
Lisaftoclax
M.D. Anderson Cancer Center
P2/3
B
(62)
Isavuconazole
Acute Myeloid Leukemia
M.D. Anderson Cancer Center
P2/3
B
(62)
Rasburicase
Cancer
M.D. Anderson Cancer Center
P4
B
(61)
Clofarabine
Acute Myeloid Leukemia With Multilineage Dysplasia
M.D. Anderson Cancer Center
P3
B
(61)
Clofarabine
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
M.D. Anderson Cancer Center
P3
B
(61)
Everolimus
Nonpapillary Renal Cell Carcinoma
M.D. Anderson Cancer Center
P3
B
(61)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
Melanoma
M.D. Anderson Cancer Center
P3
B
(61)
Anti-Thymoglobulin, Rabbit
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
M.D. Anderson Cancer Center
P2
B
(61)
Cediranib
BRCA1 Mutation Carrier
M.D. Anderson Cancer Center
P2
B
(61)
Cediranib
BRCA2 Mutation Carrier
M.D. Anderson Cancer Center
P2
B
(61)
Cediranib
Hematopoietic and Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center
P2
B
(61)
Cediranib
Inflammatory Breast Carcinoma
M.D. Anderson Cancer Center
P2
B
(61)
Cediranib
Recurrent Pancreatic Neuroendocrine Carcinoma
M.D. Anderson Cancer Center
P2
B
(61)
Cediranib
Secondary Myelofibrosis
M.D. Anderson Cancer Center
P2
B
(61)
Clofarabine
T-Cell Non-Hodgkin Lymphoma
M.D. Anderson Cancer Center
P2
B
(61)
Showing 226 to 250 of 2,003 assets
Previous
Page 10 of 81
Next